{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:05:27Z","timestamp":1759482327545},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.cct.2011.07.010","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T06:40:33Z","timestamp":1311662433000},"page":"924-930","source":"Crossref","is-referenced-by-count":3,"title":["Vasopressors and the search for the optimal trial design"],"prefix":"10.1016","volume":"32","author":[{"given":"Ritesh","family":"Maharaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2011.07.010_bb0005","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1378\/chest.121.4.1290","article-title":"The design of randomized clinical trials in critically ill patients","volume":"121","author":"Hebert","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.cct.2011.07.010_bb0010","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF02599570","article-title":"Changes in study design, gender issues, and other characteristics of clinical research published in three major medical journals from 1971 to 1991","volume":"10","author":"McDermott","year":"1995","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.cct.2011.07.010_bb0015","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1001\/jama.1993.03510210084032","article-title":"Users' guides to the medical literature. Ii. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-based medicine working group","volume":"270","author":"Guyatt","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.cct.2011.07.010_bb0020","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein c for severe sepsis","volume":"344","author":"Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cct.2011.07.010_bb0025","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cct.2011.07.010_bb0030","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The acute respiratory distress syndrome network","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cct.2011.07.010_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003709.pub2","article-title":"Vasopressors for shock","volume":"3","author":"Mullner","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cct.2011.07.010_bb0040","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/00003246-199302001-00011","article-title":"Vasoactive mediators and splanchnic perfusion","volume":"21","author":"Reilly","year":"1993","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cct.2011.07.010_bb0045","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.ccx.0000176696.70013.da","article-title":"Vasoactive drugs in the intensive care unit","volume":"11","author":"Holmes","year":"2005","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.cct.2011.07.010_bb0050","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01.CCM.0000298158.12101.41","article-title":"Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008","volume":"36","author":"Dellinger","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cct.2011.07.010_bb0055","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cct.2011.07.010_bb0060","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s00134-008-1219-0","article-title":"A comparison of epinephrine and norepinephrine in critically ill patients","volume":"34","author":"Myburgh","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cct.2011.07.010_bb0065","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cct.2011.07.010_bb0070","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/cc8990","article-title":"Delta inflation: A bias in the design of randomized controlled trials in critical care medicine","volume":"14","author":"Aberegg","year":"2010","journal-title":"Critical care (London, England)"},{"key":"10.1016\/j.cct.2011.07.010_bb0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.106.614859","article-title":"Survival methods","volume":"115","author":"Rao","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.cct.2011.07.010_bb0080","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/cc3949","article-title":"Survival methods, including those using competing risk analysis, are not appropriate for intensive care unit outcome studies","volume":"10","author":"Schoenfeld","year":"2006","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.cct.2011.07.010_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/cc3949","article-title":"Survival methods, including those using competing risk analysis, are not appropriate for intensive care unit outcome studies","volume":"10","author":"Schoenfeld","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.cct.2011.07.010_bb0090","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/sj.bjc.6602102","article-title":"A note on competing risks in survival data analysis","volume":"91","author":"Satagopan","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cct.2011.07.010_bb0095","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.108.809707","article-title":"Optimizing trial design: sequential, adaptive, and enrichment strategies","volume":"119","author":"Mehta","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cct.2011.07.010_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0197-2456(88)90034-7","article-title":"Organization, review, and administration of cooperative studies (greenberg report): a report from the heart special project committee to the national advisory heart council, may 1967","volume":"9","year":"1988","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.cct.2011.07.010_bb0105","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2307\/2530298","article-title":"Interim analyses for randomized clinical trials: the group sequential approach","volume":"38","author":"Pocock","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/j.cct.2011.07.010_bb0110","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0002-9343(85)90407-3","article-title":"The futility index. An approach to the cost-effective termination of randomized clinical trials","volume":"78","author":"Ware","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.cct.2011.07.010_bb0115","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2307\/2530245","article-title":"A multiple testing procedure for clinical trials","volume":"35","author":"O'Brien","year":"1979","journal-title":"Biometrics"},{"key":"10.1016\/j.cct.2011.07.010_bb0120","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(05)66516-6","article-title":"Multiplicity in randomised trials ii: Subgroup and interim analyses","volume":"365","author":"Schulz","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cct.2011.07.010_bb0125","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/sim.4780131308","article-title":"Interim analysis: the alpha spending function approach","volume":"13","author":"DeMets","year":"1994","journal-title":"Stat Med"},{"key":"10.1016\/j.cct.2011.07.010_bb0130","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0197-2456(00)00057-X","article-title":"Computations for group sequential boundaries using the lan-demets spending function method","volume":"21","author":"Reboussin","year":"2000","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.cct.2011.07.010_bb0135","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1259\/0007-1285-44-526-793","article-title":"Repeated assessment of results in clinical trials of cancer treatment","volume":"44","author":"Haybittle","year":"1971","journal-title":"Br J Radiol"},{"key":"10.1016\/j.cct.2011.07.010_bb0140","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/bjc.1976.220","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design","volume":"34","author":"Peto","year":"1976","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cct.2011.07.010_bb0145","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1592\/phco.21.5.405.34503","article-title":"Post hoc power analysis: an idea whose time has passed?","volume":"21","author":"Levine","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cct.2011.07.010_bb0150","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/cc8990","article-title":"Delta inflation: a bias in the design of randomized controlled trials in critical care medicine","volume":"14","author":"Aberegg","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.cct.2011.07.010_bb0155","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.0006-341X.2001.00886.x","article-title":"Adaptive group sequential designs for clinical trials: combining the advantages of adaptive and of classical group sequential approaches","volume":"57","author":"Muller","year":"2001","journal-title":"Biometrics"},{"key":"10.1016\/j.cct.2011.07.010_bb0160","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/sim.1688","article-title":"Increasing the sample size when the unblinded interim result is promising","volume":"23","author":"Chen","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.cct.2011.07.010_bb0165","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.0006-341X.1999.00874.x","article-title":"A unifying family of group sequential test designs","volume":"55","author":"Kittelson","year":"1999","journal-title":"Biometrics"},{"key":"10.1016\/j.cct.2011.07.010_bb0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-3-11","article-title":"Adaptive design methods in clinical trials \u2014 a review","volume":"3","author":"Chow","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cct.2011.07.010_bb0175","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/bimj.200900003","article-title":"Adaptive patient enrichment designs in therapeutic trials","volume":"51","author":"Wang","year":"2009","journal-title":"Biom J"},{"key":"10.1016\/j.cct.2011.07.010_bb0180","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/CCM.0b013e3181921349","article-title":"Toward theragnostics","volume":"37","author":"Pene","year":"2009","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.cct.2011.07.010_bb0185","first-page":"522","article-title":"Adaptive trial design","volume":"5","author":"Berry","year":"2007","journal-title":"Clin Adv Hematol Oncol"},{"key":"10.1016\/j.cct.2011.07.010_bb0190","doi-asserted-by":"crossref","unstructured":"Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH, Flynn DN, Elamin MB, Murad MH, Abu Elnour NO, Lampropulos JF, Sood A, Mullan RJ, Erwin PJ, Bankhead CR, Perera R, Ruiz Culebro C, You JJ, Mulla SM, Kaur J, Nerenberg KA, Schunemann H, Cook DJ, Lutz K, Ribic CM, Vale N, Malaga G, Akl EA, Ferreira-Gonzalez I, Alonso-Coello P, Urrutia G, Kunz R, Bucher HC, Nordmann AJ, Raatz H, da Silva SA, Tuche F, Strahm B, Djulbegovic B, Adhikari NK, Mills EJ, Gwadry-Sridhar F, Kirpalani H, Soares HP, Karanicolas PJ, Burns KE, Vandvik PO, Coto-Yglesias F, Chrispim PP, Ramsay T. Stopping randomized trials early for benefit and estimation of treatment effects: Systematic review and meta-regression analysis. Jama.303:1180\u20131187.","DOI":"10.1001\/jama.2010.310"},{"key":"10.1016\/j.cct.2011.07.010_bb0195","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jclinepi.2007.07.016","article-title":"Early stopping of randomized clinical trials for overt efficacy is problematic","volume":"61","author":"Bassler","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cct.2011.07.010_bb0200","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1001\/jama.294.17.2203","article-title":"Randomized trials stopped early for benefit: a systematic review","volume":"294","author":"Montori","year":"2005","journal-title":"Jama"},{"key":"10.1016\/j.cct.2011.07.010_bb0205","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1097\/01.CCM.0000174484.77537.F2","article-title":"The sirens are singing: the perils of trusting trials stopped early and subgroup analyses","volume":"33","author":"Martin","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cct.2011.07.010_bb0210","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1001\/jama.294.17.2228","article-title":"When (not) to stop a clinical trial for benefit","volume":"294","author":"Pocock","year":"2005","journal-title":"Jama"},{"key":"10.1016\/j.cct.2011.07.010_bb0215","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/bimj.200710436","article-title":"Group sequential and adaptive designs \u2014 a review of basic concepts and points of discussion","volume":"50","author":"Vandemeulebroecke","year":"2008","journal-title":"Biom J"},{"key":"10.1016\/j.cct.2011.07.010_bb0220","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/bimj.200510239","article-title":"Confirmatory clinical trials with an adaptive design","volume":"48","author":"Koch","year":"2006","journal-title":"Biom J"},{"key":"10.1016\/j.cct.2011.07.010_bb0225","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/bmj.330.7495.843","article-title":"Treatment allocation by minimisation","volume":"330","author":"Altman","year":"2005","journal-title":"BMJ"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714411001844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714411001844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T06:15:19Z","timestamp":1560406519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714411001844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1551714411001844"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2011.07.010","relation":{},"ISSN":["1551-7144"],"issn-type":[{"value":"1551-7144","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}